Clinical Trials Browser

Phase 1/2 × UNKNOWN × Irinotecan × Clear all

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03545711 2018-08-06

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms